Transcriptomics‐Based Liquid Biopsy for Early Detection of Recurrence in Locally Advanced Gastric Cancer
2024

Liquid Biopsy for Early Detection of Recurrence in Gastric Cancer

Sample size: 330 publication 10 minutes Evidence: high

Author Information

Author(s): P. Ding, J. Wu, H. Wu, T. Li, X. Niu, P. Yang, H. Guo, Y. Tian, J. He, J. Yang, R. Gu, L. Zhang, N. Meng, X. Li, Z. Guo, L. Meng, Q. Zhao

Primary Institution: The Fourth Hospital of Hebei Medical University

Hypothesis

Can a transcriptomics-based liquid biopsy improve early detection of recurrence in locally advanced gastric cancer?

Conclusion

The study developed a non-invasive liquid biopsy method using a 4-mRNA panel that significantly improves early detection of recurrence in locally advanced gastric cancer.

Supporting Evidence

  • The 4-mRNA panel showed an AUC of 0.919 in the validation cohort.
  • Patients classified as high-risk had a significantly lower 5-year overall survival rate.
  • The RSA model outperformed traditional clinical models in predicting recurrence.
  • Silencing the mRNA panel genes impaired cancer cell migration and invasion.
  • The study identified four mRNAs significantly upregulated in recurrent gastric cancer tissues.
  • The model demonstrated high predictive accuracy for recurrence detection.
  • Functional studies indicated the mRNA panel's role in promoting cancer progression.
  • The approach offers a non-invasive alternative to traditional diagnostic methods.

Takeaway

Doctors found a new way to check for cancer coming back by looking at special markers in the blood, which helps catch it early and treat it better.

Methodology

The study used mRNA sequencing and qRT-PCR to identify and validate a 4-mRNA panel in tissue and blood samples from gastric cancer patients.

Potential Biases

Potential bias due to the retrospective nature of some analyses and the specific patient populations studied.

Limitations

The study primarily focused on the predictive performance of the 4-mRNA panel without exploring specific clinical implications or decision-making algorithms.

Participant Demographics

Patients with locally advanced gastric cancer, including those undergoing surgical resection and liquid biopsy.

Statistical Information

P-Value

<0.001

Confidence Interval

95% CI: 0.825-0.902

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1002/advs.202406276

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication